Iran Dismisses U.S. Peace Plan

Plus: President Trump plans to name some of the biggest names in business to a tech advisory panel. And drugmaker Merck acquires Terns Pharmaceutical for $6 billion to gain access to a promising cancer treatment. Alex Ossola hosts. Sign up for WSJ’s free What’s News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.